TYK Medicines, Inc (HKG:2410)
Hong Kong · Delayed Price · Currency is HKD 7.47
+0.31 (4.33%)
Jul 10, 2026, 10:05 AM HKT
TYK Medicines Market Cap
TYK Medicines has a market cap or net worth of 2.75 billion as of July 9, 2026. Its market cap has decreased by -62.49% in one year.
Market Cap
2.75B
Enterprise Value
2.52B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
7.47
Market Cap Chart
Since August 20, 2024, TYK Medicines's market cap has decreased from 5.08B to 2.75B, a decrease of -45.79%. That is a compound annual growth rate of -27.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 2.75B | -44.72% |
| Dec 31, 2025 | 4.98B | -71.50% |
| Dec 31, 2024 | 17.48B | 244.16% |
| Aug 20, 2024 | 5.08B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medtide | 3.14B |
| Laekna | 3.03B |
| Antengene Corporation | 2.91B |
| BioDlink International Company | 2.77B |
| Viva Biotech Holdings | 2.54B |
| Beijing Luzhu Biotechnology | 2.53B |
| HJ Science | 2.50B |
| PegBio | 2.22B |